Passenger plane crashes in CubaWorld April 29, 22:49
US anti-missile systems in Eastern Europe violate INF Treaty - Russian foreign ministryRussian Politics & Diplomacy April 29, 20:35
Moscow police say 250 people take part in protest rallyWorld April 29, 16:29
Abe plans to continue dialogue with Putin to solve global issuesWorld April 29, 14:50
Moscow is ready to cooperate with Washington on Syria — LavrovRussian Politics & Diplomacy April 29, 12:24
Diplomat calls US’ allegations about isolation of Russia in UN 'strange'Russian Politics & Diplomacy April 28, 20:58
Experts slam 'Russian hacking' hype as 'fake news' to feed US media's ratingsRussian Politics & Diplomacy April 28, 20:35
Ferrari drivers clock best time in Practice Two of Russia F1 GP in SochiSport April 28, 19:54
Red Bull’s advisor Marko says Kvyat to possibly remain with Toro Rosso next yearSport April 28, 19:16
GENEVA, October 2. /TASS/. The World Health Organization (WHO) on Wednesday published new data, in line with which the death toll from the Ebola virus outbreak has reached 3,338 people out of a total of 7,178 officially registered cases.
The WHO report says the epidemic spread has slowed down for a second week. At the same time, the global health body warned that some cases could be underreported. The figures are cited as of the end of last week, September 28.
The Ebola virus disease (EVD), previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO website. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate. No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.